CTOs on the Move

Radiant Pain Relief Centres

www.radiantpainrelief.com

 
Our mission is to change people’s lives by reducing pain and offering services and support to enhance wellness, vitality and prosperity. Radiant Health Management owns and runs progressive, profitable treatment centers that offer cutting-edge therapies and services that improve people’s lives by reducing pain and restoring hope and function. Our Radiant Pain Relief Centres offer a highly refined and patient centered care model, built around an exclusive FDA-cleared pain treatment technology that create significant and lasting pain relief without drugs, needles or surgery.
  • Number of Employees: 0-25
  • Annual Revenue: > $1 Billion

Executives

Name Title Contact Details

Similar Companies

Volpara Health

Volpara Health provides an advanced AI software platform that enables a high-quality, optimized and personalized cancer screening experience. From the time a patient enters a clinic to the moment they obtain key results, the Volpara Breast Health Platform collects and analyzes information to better understand a patient`s breast cancer risk, while also objectively evaluating image quality and workflow-improvement opportunities. More than thirteen million women across 39 countries have had their breast density assessed by Volpara. The company`s software is installed in approximately 2000 leading facilities worldwide, including top cancer centers in the United States. Volpara Health`s technology has been the subject of more than 300 publications. The Volpara Breast Health Platform is supported by numerous patents, trademarks, and regulatory registrations, including FDA clearance and CE marking.

VitaPath Genetics

VitaPath Genetics is a San Mateo, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Welcome Nursing Home Inc

Welcome Nursing Home Inc is a Oberlin, OH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Outcome Concept Systems

Outcome Concept Systems is a Seattle, WA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

PharmaBlock Sciences

PharmaBlock Sciences (Nanjing), Inc. is a leading innovative chemistry products and services provider throughout the pharmaceutical R&D process. Its core businesses include: a catalog of specially designed scaffolds and building blocks; custom synthesis; process development; manufacturing of key intermediates and RSMs; and FTE services. The company was listed on Shenzhen Exchange Stock in China on November 10, 2017. PharmaBlock has rapidly gained recognition for its outstanding capability in the design, synthesis, and supply of lab scale building blocks. Building on that success, the company acquired Shandong Diai Biotechnology Co., Ltd. as its pilot plant and manufacturing site in 2016, and is providing scale-up synthesis and manufacturing of key intermediates/RSMs. PharmaBlock is now committed to a more comprehensive and long-term service to valued customers.